<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font6" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font7" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font8" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font9" size="9" family="GillSans,BoldItalic" color="#000000"/>
<text top="41" left="55" width="137" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>Cell Communication and Signaling</i></text>
<text top="41" left="192" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2005, </text>
<text top="41" left="220" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>3</b></text>
<text top="41" left="225" width="12" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:10</text>
<text top="41" left="383" width="171" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.biosignaling.com/content/3/1/10</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t6" reading_order_no="146" segment_no="13" tag_type="text">Page 8 of 10</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="147" segment_no="14" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">are linked to the increased vasodilatation, vascular perme-</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="2" tag_type="text">ability and hyperalgesic responses of inflammation<a href=""> [2]</a>. In</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="2" tag_type="text">other models, induction of iNOS by these same agonists</text>
<text top="122" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="2" tag_type="text">to generate nitric oxide contributes to the nociceptive</text>
<text top="134" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="2" tag_type="text">processing of inflam<a href="">matory pain [19]</a>. Therefore, we sug-</text>
<text top="145" left="55" width="121" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="2" tag_type="text">gest that chronic urothelial </text>
<text top="143" left="176" width="5" height="13" font="font5" id="p1_t14" reading_order_no="11" segment_no="2" tag_type="text">β</text>
<text top="145" left="181" width="115" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="2" tag_type="text">-AR stimulation leading to</text>
<text top="157" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="2" tag_type="text">increased levels of prostaglandins and NO is one potential</text>
<text top="169" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="2" tag_type="text">mechanism of inflammatory pain in IC. Moreover, higher</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="2" tag_type="text">levels of prostanoids and NO may also contribute to the</text>
<text top="192" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="2" tag_type="text">symptomatic increases in urinary frequency and urgency</text>
<text top="204" left="55" width="149" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="2" tag_type="text">diagnosed in patients<a href=""> with IC [4,8].</a></text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="6" tag_type="text">Support of this hypothesis has been reported using a</text>
<text top="239" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="6" tag_type="text">mouse model of bladder inflammation in which genes</text>
<text top="251" left="55" width="121" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="6" tag_type="text">encoding for iNOS and the </text>
<text top="249" left="176" width="5" height="13" font="font5" id="p1_t24" reading_order_no="21" segment_no="6" tag_type="text">β</text>
<text top="256" left="182" width="4" height="6" font="font6" id="p1_t25" reading_order_no="22" segment_no="6" tag_type="text">2</text>
<text top="251" left="185" width="111" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="6" tag_type="text">-AR subtype were upregu-</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="6" tag_type="text">lated when compared to control <a href="">[11</a>]. Interestingly, a</text>
<text top="275" left="55" width="217" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="6" tag_type="text">significant increase in genomic expression of the </text>
<text top="272" left="272" width="5" height="13" font="font5" id="p1_t29" reading_order_no="26" segment_no="6" tag_type="text">β</text>
<text top="279" left="277" width="4" height="6" font="font6" id="p1_t30" reading_order_no="27" segment_no="6" tag_type="text">2</text>
<text top="275" left="281" width="15" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="6" tag_type="text">-AR</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="6" tag_type="text">subtype was only observed in a chronic and not an acute</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="6" tag_type="text">bladder inflammation model. Conversely, other investi-</text>
<text top="310" left="55" width="220" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="6" tag_type="text">gators have shown using transient application of </text>
<text top="308" left="276" width="5" height="13" font="font5" id="p1_t35" reading_order_no="32" segment_no="6" tag_type="text">β</text>
<text top="310" left="281" width="15" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="6" tag_type="text">-AR</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="6" tag_type="text">agonists that an increase in cAMP is sufficient to generate</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="6" tag_type="text">maintenance levels of NO in primary rat urothelial cells</text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="6" tag_type="text">[<a href="">20]. H</a>owever, our studies using a human urothelial cell</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="6" tag_type="text">model, demonstrates that cAMP-dependent PKA activa-</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="6" tag_type="text">tion is not necessary to induce inflammatory mechanisms</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="6" tag_type="text">for generating NO. Moreover, generation of homeostatic</text>
<text top="392" left="55" width="200" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="6" tag_type="text">levels of NO in the rat model was sensitive to Ca</text>
<text top="392" left="255" width="9" height="6" font="font6" id="p1_t44" reading_order_no="41" segment_no="6" tag_type="text">2+ </text>
<text top="392" left="264" width="32" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="6" tag_type="text">indicat-</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="6" tag_type="text">ing that the responsible enzyme was eNOS, although tran-</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="6" tag_type="text">scriptional message (mRNA) for iNOS was well</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="6" tag_type="text">documented in this same repo<a href="">rt [20]. This</a> suggests that</text>
<text top="439" left="55" width="34" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="6" tag_type="text">chronic </text>
<text top="437" left="89" width="5" height="13" font="font5" id="p1_t50" reading_order_no="47" segment_no="6" tag_type="text">β</text>
<text top="439" left="94" width="202" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="6" tag_type="text">-AR stimulation may induce expression of iNOS,</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="6" tag_type="text">which would generate higher levels of NO contributing to</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="6" tag_type="text">the production of inflammatory pain and increased mic-</text>
<text top="474" left="55" width="114" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="6" tag_type="text">turition associated with IC.</text>
<text top="498" left="55" width="221" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="10" tag_type="text">In our human urothelial cell model we document a </text>
<text top="496" left="276" width="5" height="13" font="font5" id="p1_t56" reading_order_no="53" segment_no="10" tag_type="text">β</text>
<text top="498" left="281" width="15" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="10" tag_type="text">-AR</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="10" tag_type="text">stimulated, PKA-independent signaling pathway that</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="10" tag_type="text">simultaneously increases the expression of two mediators</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="10" tag_type="text">of inflammation, COX-2 and iNOS. In addition, the</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="10" tag_type="text">pathophysiology linked to increased prostaglandin and</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="10" tag_type="text">NO production correlate well with the clinical manifesta-</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t63" reading_order_no="60" segment_no="10" tag_type="text">tions associated with chronic inflammatory diseases like</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="10" tag_type="text">IC. Consequently, we believe that UROtsa cells serve as a</text>
<text top="592" left="55" width="186" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="10" tag_type="text">readily accessible model for studying the </text>
<text top="590" left="241" width="5" height="13" font="font5" id="p1_t66" reading_order_no="63" segment_no="10" tag_type="text">β</text>
<text top="592" left="246" width="50" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="10" tag_type="text">-AR-effector</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="10" tag_type="text">system associated with inflammation in IC. Nonsteroidal</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="10" tag_type="text">anti-inflammatory drugs (NSAIDs), which block the</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="10" tag_type="text">synthesis of prostaglandins by inhibiting COX, are com-</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="10" tag_type="text">monly prescribed to relieve discomforts associated with</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="10" tag_type="text">IC. Moreover, NSIADs have been shown to decrease the</text>
<text top="662" left="55" width="65" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="10" tag_type="text">amount of NO </text>
<text top="662" left="120" width="29" height="9" font="font7" id="p1_t74" reading_order_no="71" segment_no="10" tag_type="text"><i>in vivo </i></text>
<text top="662" left="149" width="147" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="10" tag_type="text">indicating the importance of COX-</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="10" tag_type="text">2 activity in regulating NO production during</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="10" tag_type="text">inflammati<a href="">on [21]</a>. Furthermore, combined pharmaco-</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="10" tag_type="text">logical inhibition of COX-2 and iNOS in a rat model of</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t79" reading_order_no="76" segment_no="10" tag_type="text">tonic pain, produces a synergistic antinociceptive effect</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="10" tag_type="text">[<a href="">22]. This d</a>ata suggests a common mechanism of action</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t81" reading_order_no="78" segment_no="3" tag_type="text">between these two drug classes, however, the associations</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="3" tag_type="text">between COX-2 and iNOS effector systems are currently</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="3" tag_type="text">unknown. Therefore, UROtsa cells represent a unique cell</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="3" tag_type="text">model whereby signal-transduction pathways common to</text>
<text top="134" left="313" width="241" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="3" tag_type="text">the induction of both COX-2 and iNOS can be investi-</text>
<text top="145" left="313" width="241" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="3" tag_type="text">gated. These studies not only may reveal novel targets of</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="3" tag_type="text">inflammatory pain that could be exploited therapeuti-</text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="3" tag_type="text">cally, but would increase our understanding of the</text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="3" tag_type="text">etiology for general bladder inflammation and hyperexcit-</text>
<text top="192" left="313" width="53" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="3" tag_type="text">ability in IC.</text>
<text top="216" left="313" width="56" height="10" font="font8" id="p1_t91" reading_order_no="88" segment_no="4" tag_type="title"><b>Conclusion</b></text>
<text top="228" left="313" width="72" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="5" tag_type="text">Stimulation of </text>
<text top="225" left="385" width="5" height="13" font="font5" id="p1_t93" reading_order_no="90" segment_no="5" tag_type="text">β</text>
<text top="228" left="391" width="163" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="5" tag_type="text">-ARs expressed on cultured human</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="5" tag_type="text">urothelial cells leads to ERK phosphorylation and produc-</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="5" tag_type="text">tion of the pro-inflammatory enzymes. While cAMP levels</text>
<text top="263" left="313" width="106" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="5" tag_type="text">rise in these cells after </text>
<text top="261" left="419" width="5" height="13" font="font5" id="p1_t98" reading_order_no="95" segment_no="5" tag_type="text">β</text>
<text top="263" left="425" width="130" height="9" font="font4" id="p1_t99" reading_order_no="96" segment_no="5" tag_type="text">-AR activation, production of</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="5" tag_type="text">COX-2 and iNOS are not dependent upon an increased</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="5" tag_type="text">cAMP regulated PKA activity. Continual initiation of AR</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="5" tag_type="text">function documented for patients diagnosed with IC</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t103" reading_order_no="100" segment_no="5" tag_type="text">would likely stimulate urothelial cell inflammatory</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t104" reading_order_no="101" segment_no="5" tag_type="text">responses thereby contributing to the etiology of this</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t105" reading_order_no="102" segment_no="5" tag_type="text">disease. Our results suggest that by focusing on common</text>
<text top="345" left="313" width="44" height="9" font="font4" id="p1_t106" reading_order_no="103" segment_no="5" tag_type="text">urothelial </text>
<text top="343" left="359" width="5" height="13" font="font5" id="p1_t107" reading_order_no="104" segment_no="5" tag_type="text">β</text>
<text top="345" left="364" width="190" height="9" font="font4" id="p1_t108" reading_order_no="105" segment_no="5" tag_type="text">-AR mediated inflammatory signaling path-</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t109" reading_order_no="106" segment_no="5" tag_type="text">ways, reasonable pathophysiological mechanisms and</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t110" reading_order_no="107" segment_no="5" tag_type="text">potential therapeutic strategies could be developed for</text>
<text top="380" left="313" width="161" height="9" font="font4" id="p1_t111" reading_order_no="108" segment_no="5" tag_type="text">chronic inflammatory diseases like IC.</text>
<text top="404" left="313" width="43" height="10" font="font8" id="p1_t112" reading_order_no="109" segment_no="7" tag_type="title"><b>Methods</b></text>
<text top="416" left="313" width="50" height="9" font="font9" id="p1_t113" reading_order_no="110" segment_no="8" tag_type="title"><i><b>Cell Culture</b></i></text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t114" reading_order_no="111" segment_no="9" tag_type="text">The immortalized human urothelial (UROtsa) cell line</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t115" reading_order_no="112" segment_no="9" tag_type="text">was a gift from Donald Sens (University of North Dakota)</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t116" reading_order_no="113" segment_no="9" tag_type="text">and was propagated as previously reported <a href="">[12]</a>. Briefly,</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t117" reading_order_no="114" segment_no="9" tag_type="text">undifferentiated UROtsa cells were grown to confluence</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t118" reading_order_no="115" segment_no="9" tag_type="text">in serum-containing Dulbecco's Modified Eagle's</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t119" reading_order_no="116" segment_no="9" tag_type="text">Medium (DMEM) under standard cell culture conditions.</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t120" reading_order_no="117" segment_no="9" tag_type="text">Confluent UROtsa cells were washed in serum-free</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t121" reading_order_no="118" segment_no="9" tag_type="text">DMEM and pre-incubated with or without inhibitors pro-</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t122" reading_order_no="119" segment_no="9" tag_type="text">tein kinase A (PKA) inhibitors 1 hr before addition of the</text>
<text top="533" left="313" width="38" height="9" font="font4" id="p1_t123" reading_order_no="120" segment_no="9" tag_type="text">selective </text>
<text top="531" left="351" width="5" height="13" font="font5" id="p1_t124" reading_order_no="121" segment_no="9" tag_type="text">β</text>
<text top="533" left="356" width="198" height="9" font="font4" id="p1_t125" reading_order_no="122" segment_no="9" tag_type="text">-AR agonist, isoproterenol. The PKA inhibitors</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t126" reading_order_no="123" segment_no="9" tag_type="text">H-89 (Sigma, St. Louis, MO) was used at a final concen-</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t127" reading_order_no="124" segment_no="9" tag_type="text">tration of 100 nM, while Rp-cAMPS (BioLog, Bremen,</text>
<text top="568" left="313" width="116" height="9" font="font4" id="p1_t128" reading_order_no="125" segment_no="9" tag_type="text">Germany) was used at 10 </text>
<text top="566" left="429" width="6" height="13" font="font5" id="p1_t129" reading_order_no="126" segment_no="9" tag_type="text">µ</text>
<text top="568" left="435" width="119" height="9" font="font4" id="p1_t130" reading_order_no="127" segment_no="9" tag_type="text">M. Unless noted otherwise,</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t131" reading_order_no="128" segment_no="9" tag_type="text">isoproterenol (Sigma, St. Louis, MO) was added to cells at</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t132" reading_order_no="129" segment_no="9" tag_type="text">a final concentration of 100 nM. As a nonspecific initiator</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t133" reading_order_no="130" segment_no="9" tag_type="text">of inflammation control, cells were incubated with 300</text>
<text top="615" left="313" width="218" height="9" font="font4" id="p1_t134" reading_order_no="131" segment_no="9" tag_type="text">nM lipopolysaccharide (CalBioChem, La Jolla, CA).</text>
<text top="639" left="313" width="98" height="9" font="font9" id="p1_t135" reading_order_no="132" segment_no="11" tag_type="title"><i><b>Membrane Preparation</b></i></text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t136" reading_order_no="133" segment_no="12" tag_type="text">A crude cell membrane preparation was prepared as previ-</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t137" reading_order_no="134" segment_no="12" tag_type="text">ously describe<a href="">d [23]</a>. Briefly, UROtsa membranes were</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t138" reading_order_no="135" segment_no="12" tag_type="text">prepared by transferring suspended cells to a 50 mL</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t139" reading_order_no="136" segment_no="12" tag_type="text">conical tube and twice washing by centrifugation at 1000</text>
<text top="698" left="313" width="8" height="9" font="font4" id="p1_t140" reading_order_no="137" segment_no="12" tag_type="text">× </text>
<text top="698" left="322" width="7" height="9" font="font7" id="p1_t141" reading_order_no="138" segment_no="12" tag_type="text"><i>g </i></text>
<text top="698" left="330" width="224" height="9" font="font4" id="p1_t142" reading_order_no="139" segment_no="12" tag_type="text">using cold Hank's balance salt solution (HBSS). The</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t143" reading_order_no="140" segment_no="12" tag_type="text">intact cell pellet was resuspended in 10 mL of 0.25 M</text>
<text top="721" left="313" width="94" height="9" font="font4" id="p1_t144" reading_order_no="141" segment_no="12" tag_type="text">sucrose containing 10 </text>
<text top="719" left="407" width="6" height="13" font="font5" id="p1_t145" reading_order_no="142" segment_no="12" tag_type="text">µ</text>
<text top="721" left="412" width="84" height="9" font="font4" id="p1_t146" reading_order_no="143" segment_no="12" tag_type="text">g/mL bacitracin, 10 </text>
<text top="719" left="496" width="6" height="13" font="font5" id="p1_t147" reading_order_no="144" segment_no="12" tag_type="text">µ</text>
<text top="721" left="502" width="52" height="9" font="font4" id="p1_t148" reading_order_no="145" segment_no="12" tag_type="text">g/mL benza-</text>
</page>
</pdf2xml>
